We work hard to attract, retain, and support the most outstanding faculty.

Transplantation direct

Improvements in Patient-reported Functioning After Lung Transplant Is Associated With Improved Quality of Life and Survival.

2025

Authors: Leslie L. Seijo, Ying Gao, Chiung-Yu Huang, Legna Betancourt, Aida Venado, Steven R. Hays, Jasleen Kukreja, Daniel R. Calabrese, John R. Greenland, Jonathan P. Singer

Annals of the rheumatic diseases

ABS0706 SUSTAINABILITY OF CLINICAL RESPONSE THROUGH 2 YEARS AMONG UPADACITINIB-TREATED PATIENTS WITH AXIAL SPONDYLOARTHRITIS: DATA FROM THE SELECT-AXIS 1 AND SELECT-AXIS 2 TRIALS.

2025

Authors: V. Navarro-Compán, P.J. Mease, L.S. Gensler, M. Rudwaleit, Y. Klionsky, J. Stigler, E. Mancl, S.H. Chen, J. Urbanik, X. Baraliakos

bioRxiv : the preprint server for biology

Neural Spectral Prediction for Structure Elucidation with Tandem Mass Spectrometry.

2025

Authors: Wang R, Manjrekar M, Mahjour B, Avila-Pacheco J, Provenzano J, Reynolds E, Lederbauer M, Mashin E, Goldman S, Wang M, Weng JK, Plata DL, Clish CB, Coley CW

Annals of the rheumatic diseases

POS0920 BIMEKIZUMAB DEMONSTRATES COMPARABLE ONE-YEAR EFFICACY IN MALE AND FEMALE PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES.

2025

Authors: M. Rudwaleit, S. Ramiro, D. Poddubnyy, M. Magrey, I. van der Horst-Bruinsma, A. Deodhar, V. Taieb, D. Voiniciuc, N. de Peyrecave, L.S. Gensler

Annals of the rheumatic diseases

POS0864 ACHIEVEMENT OF REMISSION DEFINED BY ABSENCE OF OBJECTIVE SIGNS OF INFLAMMATION VERSUS ASDAS INACTIVE DISEASE IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS TREATED WITH BIMEKIZUMAB: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES.

2025

Authors: M. Rudwaleit, H. Marzo-Ortega, V. Taieb, D. Voiniciuc, A. Marten, G. Stojan, M. Kim, L.S. Gensler

Annals of the rheumatic diseases

POS0788 BIMEKIZUMAB DEMONSTRATED SUSTAINED EFFICACY AND SAFETY ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 3-YEAR RESULTS FROM TWO PHASE 3 STUDIES AND THEIR OPEN-LABEL EXTENSION.

2025

Authors: X. Baraliakos, A. Deodhar, D. van der Heijde, F. van den Bosch, M. Magrey, W.P. Maksymowych, T. Tomita, H. Xu, D. Voiniciuc, C. Prajapati, M. Manente, A. Marten, L.S. Gensler

Annals of the rheumatic diseases

POS0773 LOW UVEITIS RATES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS OR PSORIATIC ARTHRITIS TREATED WITH BIMEKIZUMAB: LONG-TERM RESULTS FROM PHASE 2B/3 TRIALS.

2025

Authors: I. van der Horst-Bruinsma, M. Brown, F. van Gaalen, N. Haroon, L.S. Gensler, A. Marten, M. Manente, G. Stojan, T. Vaux, K. White, A. Deodhar, M. Rudwaleit

Annals of the rheumatic diseases

POS0118 ASAS RECOMMENDATIONS ON REPORTING OUTCOMES OF CORE OUTCOME SET INSTRUMENTS IN AXIAL SPONDYLOARTHRITIS CLINICAL TRIALS.

2025

Authors: F. van Gaalen, V. Navarro-Compán, X. Baraliakos, F. van den Bosch, L.S. Gensler, I. Hmamouchi, R. Landewé, P. Machado, H. Marzo-Ortega, V. Rios Rodriguez, D. Poddubnyy, S. Ramiro, D. van der Heijde

Journal of Clinical Oncology

Multisite validation of biomechanical computed tomography for osteoporosis assessment and fracture prediction in patients with high-risk or metastatic prostate cancer.

2025

Authors: Samuel L. Washington, Janet M Chiang, Polly Teng, Frank Asare-Bediako, Kaiwei Lu, David Lee, Anne Schafer, Ashutosh Parajuli, Caleb Hearn, Yu-Ning Wong, Tej A. Patel, Tony M Keaveny, Daniel Bikle, Ravi Bharat Parikh

Transplantation direct

Improvements in Patient-reported Functioning After Lung Transplant Is Associated With Improved Quality of Life and Survival.

2025

Authors: Seijo LL, Gao Y, Huang CY, Betancourt L, Venado A, Hays SR, Kukreja J, Calabrese DR, Greenland JR, Singer JP